Immunic Says It Bolstered Balance Sheet Through Three-tranche Private Placement Totaling Up To $240M, Extending Cash Runway Into Q3 2025, Based On Initial $80M Tranche
Immunic Says It Bolstered Balance Sheet Through Three-tranche Private Placement Totaling Up To $240M, Extending Cash Runway Into Q3 2025, Based On Initial $80M Tranche
Immunic表示,根据最初的8000万美元资金,它通过总额高达2.4亿美元的三批私募来增强资产负债表,将现金流延至2025年第三季度
Immunic Says It Bolstered Balance Sheet Through Three-tranche Private Placement Totaling Up To $240M, Extending Cash Runway Into Q3 2025, Based On Initial $80M Tranche
Immunic表示,根据最初的8000万美元资金,它通过总额高达2.4亿美元的三批私募来增强资产负债表,将现金流延至2025年第三季度